Xi Xu

6PUBLICATIONS
10CO-AUTHORS
Molecular targetsBiomolecular modelling and designGenome structure and regulationProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 09, 2025
Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.

Qi Yang, Bao Xue, Xianjie Qiu

|Sep 11, 2025
Discovery of Tricyclic Derivative as Novel and Potent Respiratory Syncytial Virus Fusion Glycoprotein Inhibitor with an Improved Pharmacokinetic Profile.

Li'ao Zhang, Bao Xue, Mingkang Cao

|Jun 17, 2025
WRN as a Novel Target of Synthetic Lethality: Current Advances and Future Perspectives.

Yinghao Zhang, Jiamin Zhang, Cheng Tang

|Jan 24, 2025
Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue Degraders.

Yanqing Zhang, Wenjing Liu, Chao Tong

|Apr 04, 2024
Discovery of Highly Potent Solute Carrier 13 Member 5 (SLC13A5) Inhibitors for the Treatment of Hyperlipidemia.

Li'ao Zhang, Wenjun Hu, Huimin Guo

|Feb 05, 2024
Development and therapeutic potential of GSPT1 molecular glue degraders: A medicinal chemistry perspective.

Xiujin Chang, Fangui Qu, Chunxiao Li

Pageof 1

Frequent Collaborators

5 joint publications

Zhiyu Li

4 joint publications

Jinlei Bian

1 joint publications

Zhixia Qiu

1 joint publications

Qi Yang